tolcapone — Medica
Parkinson’s disease
Preferred products
- entacapone
- Ongentys (opicapone capsules)
Initial criteria
- Patient is currently receiving carbidopa/levodopa therapy
- Patient has tried an entacapone product or Ongentys (opicapone capsules) and meets ONE of the following: i) According to the prescriber, patient had significant intolerance; OR ii) According to the prescriber, patient had inadequate efficacy
- Medication is prescribed by or in consultation with a neurologist
Approval duration
1 year